Ramucirumab Plus Pembrolizumab vs Usual Care for Treatment of Stage IV or Recurrent Non-Small Cell Lung Cancer Following Immunotherapy, Pragmatica-Lung Study
Condition(s):Recurrent Lung Non-Small Cell Carcinoma; Stage IV Lung Cancer AJCC v8Last Updated:February 8, 2024Recruiting